» Articles » PMID: 16545541

Psychotic Symptoms in Children and Adolescents with 22q11.2 Deletion Syndrome: Neuropsychological and Behavioral Implications

Overview
Journal Schizophr Res
Specialty Psychiatry
Date 2006 Mar 21
PMID 16545541
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Individuals with 22q11.2 deletion syndrome (22q11DS) are at increased risk for developing schizophrenia: half of affected adolescents report transient psychotic experiences and up to 30% of adults are diagnosed with schizophrenia. Prospective studies have shown that psychotic symptoms in childhood are predictive of later schizophreniform disorders. The current study aimed to define the prevalence and correlates of psychotic symptoms (PS) in young children and adolescents with 22q11DS. Forty-three children and adolescents with 22q11DS (mean age = 10.62+/-11.19) participated in this study. The occurrence of PS and their neuropsychological and behavioral correlates were investigated through semi-structured interviews and standardized measures. Psychotic symptoms were reported in 28% of the total sample and 17% of pre-adolescent children, and associated with decreased verbal IQ scores [F(1) = 4.41, p = 0.042]. Compared to young patients without PS, young patients with PS were perceived by their parents as more anxious-depressed [F(1) = 4.76, p = 0.035] and withdrawn [F(1) = 7.63, p = 0.009], with reduced adaptive socialization skills [F(1) = 6.88, p = 0.012]. Results suggest that psychotic manifestations are present earlier than typically reported in youngsters with 22q11DS and are accompanied by reduced verbal IQ performance and decreased adaptative social skills. The symptomatic, neuropsychological and behavioral characteristics observed in the current study may constitute central markers of increased risk for psychosis in 22q11DS.

Citing Articles

Review of the Pathophysiology and Clinical Manifestations of 22q11.2 Deletion and Duplication Syndromes.

Purow J, Waidner L, Ale H Clin Rev Allergy Immunol. 2025; 68(1):23.

PMID: 40038168 DOI: 10.1007/s12016-025-09035-4.


Adaptive behaviour deficits in individuals with 3q29 deletion syndrome.

Pollak R, Burrell T, Cubells J, Klaiman C, Murphy M, Saulnier C J Intellect Disabil Res. 2023; 68(2):113-127.

PMID: 37740553 PMC: 10843465. DOI: 10.1111/jir.13094.


Psychotic symptoms and its associated factors relating to psychoactive substance use among the youth population in Northwest Ethiopia.

Kassew T, Tilahun S, Alemayehu B, Getnet B, Demilew D, Tarekegn G Front Psychiatry. 2023; 14:1045111.

PMID: 37215660 PMC: 10196362. DOI: 10.3389/fpsyt.2023.1045111.


Adaptive behavior deficits in individuals with 3q29 deletion syndrome.

Pollak R, Burrell T, Cubells J, Klaiman C, Murphy M, Saulnier C medRxiv. 2023; .

PMID: 37066139 PMC: 10104221. DOI: 10.1101/2023.03.31.23288022.


Synaptic Plasticity Dysfunctions in the Pathophysiology of 22q11 Deletion Syndrome: Is There a Role for Astrocytes?.

de Oliveira Figueiredo E, Bondiolotti B, Laugeray A, Bezzi P Int J Mol Sci. 2022; 23(8).

PMID: 35457231 PMC: 9028090. DOI: 10.3390/ijms23084412.